Japanese Pharmacopoeia 18th Edition - English Version Now Available
![Statistical Simulations for Enhanced Understanding of Analytical Performance - Live Webinar](files/eca/userImages/training.img/Z-ECA-Webinar-Statistical-Simulations.jpg)
Recommendation
Monday, 9 September 2024 14.00 - 16.00 h
The English translation of the Japanese Pharmacopoeia (JP) 18th edition is available for download free of charge.
Legal Status
The Japanese Pharmacopoeia is the pharmaceutical standard that the Japanese Minister of Health, Labour and Welfare (MHLW) establishes to regulate the properties and quality of drugs.
As with other pharmacopoeias, the document is revised periodically. The 18th edition (JP18) came into effect on June 7, 2021. The text is originally prepared in Japanese and translated to English after the publication of the Japanese version. This usually is done within one year. According to the publication schedule, Supplement I to JP18 is to be published in December 2022 and Supplement II in 2024. It is planned that the 19th edition will be published in 2026.
Content of JP18 English Version
The following documents are available as PDF files:
- General Notice - General Tests, Processes and Apparatus
- Official Monographs (A to L)
- Official Monographs (M to Z)
- Crude Drugs and Related Drugs
- Infrared Reference Spectra
- Ultraviolet-visible Reference Spectra
- General Information
Download
The English translation of the 18th version is available free of charge on the website of the Minister of Health, Labour and Welfare. There you will also find the older editions of the pharmacopoeia.
Further information is also available in the JP Frequently Asked Questions section.
Related GMP News
24.07.2024FDA Warning Letter to Chinese OTC Manufacturer for Lack of Analytical Test Data
10.07.2024Pharmeuropa: Two Revised Chapters on Dissolution Testing published for comments
03.07.2024FDA Warning Letter: GMP Requirements also apply to HPLC Analyses for Internal Use
12.06.2024NMPA Announcement on Application of ICH Q2(R2) and Q14 Principles
22.05.2024Q&As from the Live Online Training "Introduction to the AQCG's new AIQSV Guide" - Part 1
22.05.2024FDA Warning Letter to Contract Testing Laboratory in Uruguay due to Data Integrity Violations